Investor profile
Asabys Partners has backed 13 European tech companies across 16 funding rounds between 2019 and 2026, joining rounds totalling €661M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| SpliceBio | Spain | 2 | €168M |
| Agomab Therapeutics | Belgium | 1 | €83M |
| Ona Therapeutics | Spain | 1 | €74M |
| Sidekick Health | Iceland | 2 | €69M |
| Inbrain Neuroelectronics | Spain |
| Company | Stage | Amount | Date |
|---|---|---|---|
| SpliceBio | Series B | €118M | 2025-06 |
| Agomab Therapeutics | Series D+ | €83M | 2024-10 |
| Ona Therapeutics | Series B | €74M | 2026-06 |
| Sidekick Health |
| 2 |
| €61M |
| Quibim | Spain | 1 | €50M |
| Deepull | Spain | 1 | €50M |
| Qida | Spain | 1 | €37M |
| Anaconda Biomed | Spain | 1 | €20M |
| Medlumics | Spain | 1 | €18M |
| Gradient Denervation Technologies | France | 1 | €14M |
| SafeHeal | France | 1 | €10M |
| Cara Care | Germany | 1 | €6.2M |
| Series B |
| €52M |
| 2022-05 |
| SpliceBio | Series A | €50M | 2022-02 |
| Deepull | Series C | €50M | 2025-04 |
| Quibim | Series A | €50M | 2025-01 |
| Inbrain Neuroelectronics | Series B | €46M | 2024-10 |
| Qida | Other | €37M | 2025-11 |
| Anaconda Biomed | Series B | €20M | 2019-10 |
